• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Cancer - Brain Tumor Product Image

Cancer - Brain Tumor

  • ID: 599452
  • March 2008
  • 165 Pages
  • Life Science Analytics

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Brain Tumor Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects



--Top Companies in late stage Brain Tumor Projects
--Antisense Pharma GmbH
--Amgen Inc
--AstraZeneca Plc
--Ark Therapeutics Group plc
--DAIICHI SANKYO COMPANY, LIMITED
--BioNumerik Pharmaceuticals, Inc.
--Erimos Pharmaceuticals
--EntreMed Inc
--Genentech Inc
--Ethypharm SA
--MGI Pharma, Inc.
--Keryx Biopharmaceuticals Inc
--Oncovir, Inc
--Nippon Kayaku Co., Ltd.
--Roche Holdings Ltd
--Pharmacyclics Inc
--TransMolecular, Inc.
--Teva Pharmaceutical Industries Ltd
--YM BioSciences Inc
--Vion Pharmaceuticals Inc

--Top Companies in early stage Brain Tumor Projects
--Ariad Pharmaceuticals Inc
--Alfacell Corp
--BioNumerik Pharmaceuticals, Inc.
--AUSTRIANOVA Biotechnology GmbH
--Celgene Corporation
--BioWa, Inc.
--Cylene Pharmaceuticals, Inc.
--Cephalon Inc
--ESBATech AG
--Diffusion Pharmaceuticals LLC
--Lixte Biotechnology Holdings, Inc.
--Kyowa Hakko Kogyo Co., Ltd.
--Merck & Co Inc
--MediGene AG
--NeuroSearch A/S
--NatImmune A/S
--Targepeutics, Inc.
--Reata Pharmaceuticals, Inc.
--TransMolecular, Inc.
--Topotarget A/S

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos